Locust Wood Capital Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$75.1M |
| 2 |
Kenvue
KVUE
|
+$57.1M |
| 3 |
Abbott
ABT
|
+$30.8M |
| 4 |
Linde
LIN
|
+$17M |
| 5 |
UBS Group
UBS
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$59.5M |
| 2 |
Labcorp
LH
|
+$47.1M |
| 3 |
Elevance Health
ELV
|
+$25.3M |
| 4 |
Vertiv
VRT
|
+$14.2M |
| 5 |
RH
RH
|
+$13.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.05% |
| 2 | Industrials | 16.15% |
| 3 | Healthcare | 14.17% |
| 4 | Technology | 11.12% |
| 5 | Materials | 9.68% |
Similar funds
Locust Wood Capital Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Locust Wood Capital Advisers held 58 positions worth $2.35B, up 9.2% from $2.15B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Locust Wood Capital Advisers deployed $233M of net new capital in Q3 2023, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Kenvue: 2,467,788 shares worth $49.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Elevance Health, an estimated $25.3M trimmed.
- Locust Wood Capital Advisers's largest Q3 2023 buy was Kenvue: 2,467,788 shares worth $49.6M.
- Locust Wood Capital Advisers added most to UnitedHealth in Q3 2023, an estimated $75.1M increase.
- Locust Wood Capital Advisers's biggest Q3 2023 reduction was Elevance Health, cutting an estimated $25.3M.
- Locust Wood Capital Advisers fully exited Baxter International in Q3 2023, selling an estimated $59.5M.
- Locust Wood Capital Advisers's ten largest holdings make up 46% of its $2.35B portfolio in Q3 2023.
- Locust Wood Capital Advisers opened 9 new positions and closed 10 in Q3 2023.
- Locust Wood Capital Advisers's portfolio value rose 9.2% quarter-over-quarter to $2.35B.
Based on Locust Wood Capital Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.